Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016

Esben Skov Jensen1, Kevin Kris Warnakula Olesen1, Christine Gyldenkerne1

  • 1Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, Denmark.

Insights

Cardiovascular risk in diabetes patients with chronic coronary syndrome decreased by 30% from 2004-2016. While significant, this reduction was less pronounced than in non-diabetes patients during the same period.

Area of Science:

  • Cardiology
  • Diabetology
  • Public Health

Background:

  • Prior research indicated reduced cardiovascular event risk in new-onset diabetes patients without pre-existing cardiovascular disease.
  • The impact of recent advancements on cardiovascular risk in patients with chronic coronary syndrome and diabetes remained unclear.

Purpose of the Study:

  • To investigate changes in cardiovascular risk among patients diagnosed with both diabetes and chronic coronary syndrome between 2004 and 2016.

Main Methods:

  • A cohort study included patients with coronary artery disease confirmed by angiography in Western Denmark (2004-2016).
  • Patients were stratified by angiography year and followed for two years to assess major adverse cardiovascular events (MACE).
  • Analyses compared MACE risk between diabetes and non-diabetes groups, adjusting for time trends.

Main Results:

  • In 5931 diabetes patients, two-year MACE risk decreased from 8.4% (2004-2006) to 6.7% (2013-2016), a 30% relative reduction.
  • In 23,540 non-diabetes patients, MACE risk decreased from 6.3% to 3.9% over the same intervals.
  • The relative risk reduction for MACE was 30% in diabetes patients versus 43% in non-diabetes patients (2013-2016 vs 2004-2006).

Conclusions:

  • Between 2004 and 2016, the relative risk of major adverse cardiovascular events (MACE) decreased by 30% in patients with diabetes and chronic coronary syndrome.
  • Although cardiovascular risk improved in this group, the reduction was less substantial compared to patients without diabetes.
  • These findings highlight the need for continued efforts to mitigate cardiovascular risk in diabetic populations with established coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
475
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
67
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
48